Drug intelligence / Profile preview

paracetamol + pseudoephedrine

Development stage
Phase 4
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Oral
01

Overview

Paracetamol + pseudoephedrine is a fixed-dose combination of two active ingredients commonly used to relieve symptoms associated with upper respiratory tract infections, such as headache, fever, body aches, nasal congestion, and sinus pressure. Paracetamol (also known as acetaminophen) acts as an analgesic and antipyretic by inhibiting prostaglandin synthesis in the central nervous system. Pseudoephedrine is a sympathomimetic amine that acts primarily as an agonist at alpha adrenergic receptors in the nasal mucosa, causing vasoconstriction which reduces swelling and congestion. The combination provides both pain relief/fever reduction from paracetamol and decongestant effects from pseudoephedrine[1][5]. It is widely available under various brand names for over-the-counter use in cold, flu, or allergy-related conditions.

Brand names
Allerest No DrowsinessNexafed Sinus Pressure + PainOrnexAlka-Seltzer Cold and SinusBayer Select DecongestantCold and Flu Day (Cipla)Cold and Flu Relief Day/Night (Apohealth)Cold and Flu Day/Night (Cipla)
Other names
acetaminophen + pseudoephedrine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRA1A (α1A)

Beyond the preview

Go deeper on paracetamol + pseudoephedrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + pseudoephedrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call